Jackson Creek Investment Advisors LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1831003
CASTLE ROCK, CO
Position in NBIX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,793,602
New position
Shares Held
10,642
first reported quarter
Ownership
0.010%
of shares outstanding
% of Portfolio
0.92%
of 13F equity value
Holder Rank
#324
of 768 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Jackson Creek Investment Advisors LLC holds $8,805,246 across 7 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (20.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
49,619 | $2,035,867 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
10,642 | $1,793,602 | |
| 3 | COLL |
Collegium Pharmaceutical, Inc
|
42,663 | $1,544,400 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
14,298 | $1,183,588 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
40,140 | $987,845 | |
| 6 | ALKS |
Alkermes plc.
|
13,161 | $689,636 | |
| 7 | LQDA |
Liquidia Corp
|
7,153 | $570,308 |
All Filings in NBIX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,793,602 | 10,642 | Shares | Sole | 2026-08-10 | |
| No filing history on record for this holder in this stock. | ||||||